ライフサイエンスコーパス: complete resection

1 ations ranging from 0.0 (no lesion) to 10.0 (complete resection).

2 Twenty patients (48%) received a primary complete resection.

3 6%) of 91 patients had a SN identified and a complete resection.

4 s of metastases, and the ability to obtain a complete resection.

5 ival and increased likelihood of achieving a complete resection.

6 ze and multiorgan involvement that precludes complete resection.

7 plete resection, and three others also had a complete resection.

8 tic factors are stage and ability to achieve complete resection.

9 olved as an effective method for macroscopic complete resection.

10 mas (LGGs) in areas of the brain amenable to complete resection.

11 ibutable to metastatic disease undetected at complete resection.

12 asive carcinoma, they should be treated with complete resection.

13 ifteen of the sixteen tumors were successful complete resection.

14 cer (NSCLC) have a poor prognosis even after complete resection.

15 idual viable tumor and only three achieved a complete resection.

16 1.8%) died postoperatively, and 83 (76%) had complete resection.

17 Of the 56 patients who underwent complete resection, 34 (61%) had gastrointestinal stroma

18 However, despite complete resection, 5-year survival rates have been disa

19 Fourteen sequences showing complete resection according to the 5-ALA technique coul

20 Twenty-one experimental sequences showing complete resection according to the 5-ALA technique were

21 otal of 1616 patients with a microscopically complete resection (according to local pathologists), in

22 o be tumor-free had no events; those who had complete resections achieved a 5-year EFS of 83% (SD = 6

23 ry cardiac tumors appear to benefit from the complete resection afforded by cardiectomy and transplan

24 previously treated, 47% were able to undergo complete resection after combined HAI and systemic thera

25 Likelihood of complete resection after recurrence (all sites) increase

26 is necessary to determine the likelihood of complete resection although debulking surgery often is b

27 of oral IEN varies from watchful waiting to complete resection, although complete resection does not

28 radiation plus surgery, yields a 50% rate of complete resection and a 30% 5-year survival.

29 ients with pathologic N2 NSCLC who underwent complete resection and adjuvant chemotherapy from 2006 t

30 For patients with N2 NSCLC after complete resection and adjuvant chemotherapy, modern POR

31 ession-free survival rate was better after a complete resection and in older patients.

32 For the 45 patients undergoing complete resection and IOERT, the 5-year actuarial local

33 ed with our earlier experience, the rates of complete resection and overall survival have improved.

34 easible and is associated with high rates of complete resection and pathologic CR in both T3 and T4 t

35 hat long-term survival was associated with a complete resection and the preoperative staging strategy

36 Fifty-one patients undergoing complete resection and/or ablation for colorectal hepati

37 44.7+), two had no residual disease found at complete resection, and three others also had a complete

38 Nephrectomy may be needed to achieve complete resection, but has no measurable influence on d

39 529 patients with epithelioid MPM underwent complete resection by EPP as part of a multimodality str

40 s in prognosis and outcome in patients after complete resection by examining a large cohort of STS pa

41 ction should be performed in patients when a complete resection can be realistically obtained and whe

42 scularis propria layer and larger than 2 cm, complete resection can be successfully performed without

43 , but when executed, Artemis is essential to complete resection-dependent c-NHEJ.

44 hful waiting to complete resection, although complete resection does not prevent oral cancer in high-

45 Efforts are needed to ensure complete resection, especially of larger lesions.

46 surgeon remains the cornerstone of safe and complete resection for adrenal malignant disease.

47 cranial irradiation in patients who undergo complete resection for early-stage small-cell lung cance

48 y the survival of 557 patients who underwent complete resection for HCC at four centers was examined.

49 tive radiation or chemoradiation followed by complete resection for locally advanced rectal cancer de

50 tion as well as increasing the likelihood of complete resection for pituitary tumours and gliomas.

51 ven advantage to adjuvant chemotherapy after complete resection for specific stage groups, new techni

52 Patients treated with complete resection had a median survival of 33 months an

53 ntraoperatively resulted in a radiologically complete resection in 24 (80%) of 30 patients.

54 Surgery consisted of complete resection in 62 (69.7%) patients, partial resec

55 with pathologic T1-2N0M0 SCLC who underwent complete resection in the National Cancer Data Base from

56 The impact of complete resection in this well-selected group is contro

57 Before chemotherapy, complete resection, incomplete resection, and biopsy or

58 Recurrence of stromal tumors following complete resection is common in Carney's syndrome and pr

59 However, LGGs located in areas where complete resection is not possible can threaten both fun

60 Complete resection is required for cure.

61 Diagnosis was based on complete resection (n = 20), biopsy (n = 42), or clinica

62 r CSS of 79% versus 36% for patients without complete resection (n = 30; P < .0001).

63 had at least one local recurrence following complete resection of a primary retroperitoneal liposarc

64 Of these, 52 patients underwent complete resection of a single node.

65 A 55-year-old Caucasian female underwent complete resection of a stage IVA B3 thymoma.

66 s, complete resection of structural lesions, complete resection of abnormal electrocorticographic are

67 Complete resection of all gross residual disease was ach

68 nts (71%) with both unilateral-only IEDs and complete resection of baseline ECoG IEDs had an excellen

69 Unilateral IEDs on scalp EEG (P = .001) and complete resection of brain regions generating IEDs on b

70 logic findings in patients who had undergone complete resection of bronchial carcinoid tumors were as

71 Methods Patients who underwent a complete resection of CLM between 1992 and 2012 were inc

72 al of 2,368 consecutive patients underwent a complete resection of CLM, with a median follow-up of 55

73 overall survival (OS) in patients who had a complete resection of colorectal liver metastases (CLM).

74 ed for all patients who underwent an initial complete resection of colorectal liver metastases betwee

75 A complete resection of congenital intrahepatic bile ducts

76 n operative candidates who could not undergo complete resection of disease.

77 Complete resection of electrocorticographic and anatomic

78 Recurrence after complete resection of gastric adenocarcinoma usually occ

79 We hypothesized that complete resection of gastric GISTs using a combination

80 patients with primary disease who underwent complete resection of gross disease (n = 80), the 5-year

81 eral-only IEDs on preoperative scalp EEG and complete resection of IEDs on baseline ECoG are associat

82 s, relative risk = 0.31 [95% CI, 0.16-0.64]; complete resection of IEDs on baseline ECoG, relative ri

83 Ninety-six patients who underwent complete resection of liver metastases from colorectal c

84 Complete resection of liver metastases from sarcoma in s

85 literature have examined adjuvant HAI after complete resection of liver metastases.

86 fter completing high-dose therapy, underwent complete resection of lung metastases, and remains disea

87 result of both selection by chemotherapy and complete resection of metastatic disease.

88 The administration of adjuvant therapy after complete resection of non-small-cell lung cancer is cont

89 er, were able to have an MRI scan, and had a complete resection of one to three brain metastases (wit

90 the surgical cavity in patients who have had complete resection of one, two, or three brain metastase

91 The complete resection of pituitary adenomas (PAs) is unlike

92 Local recurrence after complete resection of primary retroperitoneal liposarcom

93 6 (including six with liver transplants) had complete resection of primary tumor.

94 Data on optimal adjuvant therapy after complete resection of small-cell lung cancer (SCLC) are

95 y (BRT) or no further therapy (no BRT) after complete resection of soft tissue sarcomas of the extrem

96 t brachytherapy improves local control after complete resection of soft tissue sarcomas.

97 The 25% rate of recurrence after complete resection of stage II colon cancer (CC) suggest

98 After patients had undergone complete resection of stage III cutaneous melanoma, we r

99 g per kilogram in patients who had undergone complete resection of stage III melanoma.

100 Gray-white blurring on MRI, smaller lesions, complete resection of structural lesions, complete resec

101 ptimum treatment consisting of selective and complete resection of the causative tumour is necessay t

102 Complete resection of the envelope of supporting tissues

103 A complete resection of the epileptogenic zone is required

104 e operated under local anaesthesia by either complete resection of the lesion with primary closure, o

105 the primary tumor and at least a macroscopic complete resection of the metastatic lesions.

106 al in patients with a local recurrence after complete resection of the primary and rerecurrence after

107 on chemotherapy, 54.7% of patients underwent complete resection of the primary tumor, 30.6% underwent

108 ctors associated with improved survival were complete resection of the tumor (P = 0.001), nonmetastat

109 r patients with hepatoblastoma, a timely and complete resection of the tumor is critical to the patie

110 bladder cancer, the mainstay of treatment is complete resection of the tumour followed by induction a

111 Of these patients, 61 underwent complete resection of their first local recurrence.

112 in survival rate for patients who underwent complete resection of their primary tumor compared with

113 y-eight patients were explored and underwent complete resection of their tumors.

114 f achieving a seizure-free outcome following complete resection of this area (p=0.008).

115 Multivariate logistic regression revealed complete resection of tissue manifesting electrocorticog

116 ay be used in image-guided surgery to ensure complete resection of tumor tissue.

117 Recurrences after complete resections of metastatic CRC remain frequent.

118 a volume </= 64cm(3) (OR = 3.17, p = 0.034), complete resection (OR = 15.50, p = 0.0009), diencephali

119 sis, surgical treatment, mutilating surgery, complete resection, or survival were not associated with

120 In a multivariate analysis, age, complete resection, pathologic stage, and pneumonectomy,

121 is significantly influenced by patient age, complete resection, pathologic stage, and pneumonectomy.

122 is as independent adverse prognosticators in complete resection patients.

123 Grossly complete resection (R0 or R1) was performed in 26 (90%)

124 Macroscopically complete resection (R0 or R1) was performed in all 26 pa

125 ars, 18-69) were identified with macroscopic complete resection (R0, R1) of abdominal and retroperito

126 cant prognostic parameters for patients with complete resections (R0) following neoadjuvant radiochem

127 Complete resections (R0) were performed in 66 of 74 (89%

128 Data are reviewed in terms of complete resection rates and disease-free survival so as

129 recurrence exerts significant influence over complete resection rates for recurrent disease.

130 Complete resection remains the most effective and only p

131 Complete resection remains the only means for cure, and

132 Complete resection remains the only therapy that offers

133 f the surgery (lobectomy: S: 56%, CT-S: 60%, complete resection: S: 80%, CT-S: 82%).

134 Complete resection (stages I and II) was achieved in 32

135 rest was to obtain long-term follow-up after complete resection to determine the recurrence rates bas

136 urvival rate of patients who did not undergo complete resection was 4%.

137 follow-up period for patients who underwent complete resection was 42 months (range, 1 to 194 months

138 r relapse-free survival for patients who had complete resection was 74% (65-83).

139 Complete resection was achieved in 86.5% of patients (n

140 Complete resection was performed in 17 patients, and ima

141 Secondary complete resection was possible in six of 10 patients wi

142 isualization of solid tumors that can enable complete resections while sparing normal surrounding tis

143 rcinoma define patients who, if they undergo complete resection, will have 100% disease-free survival

144 Improved survival after a complete resection with curative intent is often predict

145 primary or metastatic tumors of the liver is complete resection with evidence that an anatomic resect

146 unresectable colorectal-liver metastasis to complete resection with hepatic-arterial infusion plus s

147 Complete resection with negative histologic margins was

148 al resection, the surgical goal always being complete resection with negative margins.

149 of surgical intervention in this scenario is complete resection with no gross residual disease.

150 Complete resection with no tumor within 1 mm of the rese

151 vival was 44% for all patients and 54% after complete resection, with no difference between T3 and T4